Evidence map›Paper›PMID 36691997›Full record

ArticleHuman vaccines & immunotherapeutics2023

COVID-19 vaccination up-take in three districts of Nepal.

Tara Nath Pokhrel, Kshitij Karki, Bhim Singh Tinkari, Shyam Raj Upreti, Shikha Upadhyaya Khatiwada, Rakchya Amatya, John Zervos, Linda Kaljee, Kate Zenlea, Tyler Prentiss and 12 more

Open access · goldAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 2 countries.

Tara Nath PokhrelMinistry of Health and Population, Kathmandu, Nepal.
Kshitij KarkiGTA Foundation, Kathmandu, Nepal.
Bhim Singh TinkariGTA Foundation, Kathmandu, Nepal.
Shyam Raj UpretiGTA Foundation, Kathmandu, Nepal.
Shikha Upadhyaya KhatiwadaGTA Foundation, Kathmandu, Nepal.
Rakchya AmatyaGTA Foundation, Kathmandu, Nepal.
John ZervosGlobal Health Initiative, Henry Ford Health, Detroit, MI, USA.
Linda KaljeeGlobal Health Initiative, Henry Ford Health, Detroit, MI, USA.
Kate ZenleaGlobal Health Initiative, Henry Ford Health, Detroit, MI, USA.
Tyler PrentissGlobal Health Initiative, Henry Ford Health, Detroit, MI, USA.
Gina MakiDivision of Infectious Diseases, Henry Ford Health, Detroit, MI, USA.
Anita ShallalDivision of Infectious Diseases, Henry Ford Health, Detroit, MI, USA.
Seema JoshiDivision of Infectious Diseases, Henry Ford Health, Detroit, MI, USA.
Marcus ZervosDivision of Infectious Diseases, Henry Ford Health, Detroit, MI, USA.
Katie LatackDepartment of Public Health Sciences, Henry Ford Health, Detroit, MI, USA.
Bidushi PokhrelHospital for Advanced Medicine and Surgery, Kathmandu, Nepal.
Alina UpretiKathmandu Model Hospital, Kathmandu, Nepal.
Bibek Kumar LalFamily Welfare Division, Department of Health Services, Ministry of Health and Population, Kathmandu, Nepal.
Sagar DahalFamily Welfare Division, Department of Health Services, Ministry of Health and Population, Kathmandu, Nepal.
Jhalak Sharma GautamManagement Division, Department of Health Services, Ministry of Health and Population, Kathmandu, Nepal.
Dipendra Raman SinghDepartment of Health Services, Ministry of Health and Population, Kathmandu, Nepal.
Deepak C BajracharyaGTA Foundation, Kathmandu, Nepal.
Henry Ford Health System · USHimalayan Rescue Association · NPMinistry of Health and Population · NPTech Foundation · USDepartment of Health Services · NPCivil Service Hospital · NPKathmandu Medical College Teaching Hospital · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccine hesitancy during the COVID-19 pandemic continues to be an issue in terms of global efforts to decrease transmission rates. Despite high demand for the vaccines in Nepal, the country still contends with challenges related to vaccine accessibility, equitable vaccine distribution, and vaccine hesitancy. Study objectives were to identify: 1) up-take and intention for use of COVID-19 vaccines, 2) factors associated with vaccine up-take, and 3) trusted communication strategies about COVID-19 and the vaccines. A quantitative survey was implemented in August and September 2021 through an initiative at the Nepali Ministry of Health and Population Department of Health Services, Family Welfare Division. Data were collected from 865 respondents in three provinces (Bagmati, Lumbini, and Province 1). Ordinal multivariate logistic regression was utilized to determine relationships between vaccination status and associated factors. Overall, 62% (537) respondents were fully vaccinated and 18% (159) were partially vaccinated. Those respondents with higher education (

Indexed as

COVID-19COVID-19 VaccinesHumansNepalPandemicsVaccinationCOVID-19 VaccinesCOVID-19NepalpandemicSouth Asiavaccine acceptancevaccine hesitancy

Identifiers

PMID36691997
PMCPMC9988332
OpenAlexW4317871337

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.